Condensed Consolidated Statements of Cash Flows (Unaudited) - USD ($) $ in Millions	9 Months Ended
	Sep. 30, 2016	Sep. 30, 2015
Cash flows from operating activities
Net earnings	$ 5,051	$ 5,318
Adjustments to reconcile net earnings to net cash provided by/(used for) operating activities
Depreciation and amortization	731	706
Share-based compensation	1,943	2,107
Gain related to extinguishment of junior subordinated debt		(34)
Changes in operating assets and liabilities
Cash and securities segregated for regulatory and other purposes	2,312	(6,452)
Receivables and payables (excluding loans receivable), net	(13,524)	4,524
Collateralized transactions (excluding other secured financings), net	2,794	(12,902)
Financial instruments owned, at fair value	5,386	18,366
Financial instruments sold, but not yet purchased, at fair value	(29)	(6,753)
Other, net	(2,891)	(4,714)
Net cash provided by operating activities	1,773	166
Cash flows from investing activities
Purchase of property, leasehold improvements and equipment	(2,063)	(1,205)
Proceeds from sales of property, leasehold improvements and equipment	332	120
Net cash acquired in/(used for) business acquisitions	15,754	(1,684)
Proceeds from sales of investments	1,209	714
Loans receivable, net	(3,930)	(12,692)
Net cash provided by/(used for) investing activities	11,302	(14,747)
Cash flows from financing activities
Unsecured short-term borrowings, net	140	(1,228)
Other secured financings (short-term), net	395	(492)
Proceeds from issuance of other secured financings (long-term)	2,377	10,772
Repayment of other secured financings (long-term), including the current portion	(6,486)	(7,360)
Purchase of APEX, senior guaranteed securities and trust preferred securities	(1,171)	(1)
Proceeds from issuance of unsecured long-term borrowings	39,134	36,031
Repayment of unsecured long-term borrowings, including the current portion	(29,198)	(22,513)
Derivative contracts with a financing element, net	81	(89)
Deposits, net	10,510	8,578
Common stock repurchased	(4,590)	(2,545)
Dividends and dividend equivalents paid on common stock, preferred stock and share-based awards	(1,238)	(1,197)
Proceeds from issuance of preferred stock, net of issuance costs	1,303	1,993
Proceeds from issuance of common stock, including exercise of share-based awards	1	220
Excess tax benefit related to share-based awards	97	388
Cash settlement of share-based awards		(1)
Net cash provided by financing activities	11,355	22,556
Net increase in cash and cash equivalents	24,430	7,975
Cash and cash equivalents, beginning of year	75,105	57,600
Cash and cash equivalents, end of period	$ 99,535	$ 65,575